Dora Lalic | Emerging Technologies Shaping Longevity | Milan Longevity Summit 2026

*Glycans as Biomarkers for Personalized Health Tracking* Can our biology tell us whether the changes we make are actually helping us age better? In this session from *Emerging Technologies Shaping Longevity* at the *Milan Longevity Summit 2026*, *Dora Lalic* explores the emerging use of glycans as dynamic biomarkers for tracking biological health and ageing. Glycans are complex sugar molecules attached to proteins that play important roles in immunity and inflammation. Their patterns change with age, disease, lifestyle, and other biological influences, making them a promising tool for understanding how an individual's health is changing over time. Lalic examines how glycan biomarkers could move health tracking beyond static measurements, enabling more personalised monitoring of biological ageing and potentially helping individuals and clinicians understand how lifestyle or therapeutic interventions are influencing health. Dora Lalic is a Clinical Scientist at *GlycanAge*, where her work focuses on translating advances in glycobiology into tools for measuring biological age, immune health, and personalised health trajectories. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. *Learn more about the Milan Longevity Summit:* https://www.milanlongevitysummit.org/it/speakers26/dora-lalic #MilanLongevitySummit #Longevity #OneHealth #DoraLalic #Glycans #Biomarkers #BiologicalAge #PersonalizedHealth #HealthyAgeing #Healthspan